查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1939509

犬用葡萄糖胺补充剂市场按剂型、成分类型、配方和分销管道划分，全球预测（2026-2032年）

Glucosamine Supplement for Dog Market by Form, Ingredient Type, Composition, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，犬用葡萄糖胺补充剂市场价值将达到 2.3644 亿美元，到 2026 年将增长至 2.5755 亿美元，到 2032 年将达到 3.8654 亿美元，复合年增长率为 7.27%。

关键市场统计数据
基准年 2025 2.3644亿美元
预计年份：2026年 2.5755亿美元
预测年份 2032 3.8654亿美元
复合年增长率 (%) 7.27%

一个实施框架，阐明了犬类关节健康领域产品创新、供应链韧性和不断变化的宠物饲主期望之间的策略交集。

本导言为犬用葡萄糖胺补充剂领域的相关人员建立了策略背景，并阐述了为何如今采取以证据为基础、目标明确的策略至关重要。该品类正处于宠物饲主期望不断变化、配方科学不断进步以及日益重视便利性和临床可靠性的分销环境的交汇点。因此，为了保持竞争力，企业必须将产品创新与供应链韧性、法规遵循度和差异化的市场推广模式结合。

对推动犬类营养补充剂市场产品差异化、全通路分销和供应链透明度的关键变化进行了深入分析。

犬用葡萄糖胺补充剂的市场环境正经历着变革性的变化，这些变化正在重塑竞争格局，并影响着产品生命週期内的价值创造。首先，消费者的期望已不再局限于简单的症状缓解，而是转向全面的关节健康解决方案，这推动了对多种配方、补充活性成分以及循证声明的需求。这种转变迫使品牌投资于临床检验，并阐明能够引起兽医和专业宠物饲主共鸣的差异化价值提案。

对 2025 年关税主导的贸易波动如何迫使供应链重组、价格调整以及价值链上的策略供应商多元化进行严格评估。

2025年美国关税及相关贸易政策的累积影响波及整个犬类营养补充品价值链，促使企业对采购、定价和库存管理策略进行策略性重新评估。进口关税的提高和海关审查的加强推高了某些原料和包装组件的到岸成本，挤压了毛利率，迫使企业调整商业策略。为此，许多企业实施了产品组合优化，优先发展高利润产品，推迟业绩不佳的产品上市，同时也评估其他采购方案。

详细的細項分析揭示了产品形式、成分化学、分销管道趋势、生命週期阶段目标和配方如何决定商业性机会和营运重点。

细分市场洞察揭示了产品、通路和生命週期策略的交汇点，以及透过差异化创造永续竞争优势的潜力。根据剂型，市场分析涵盖咀嚼片、液体、粉末和片剂。咀嚼片又根据牛肉、鸡肉和花生酱等热门口味进一步细分，这些口味会影响宠物的偏好和復购率。剂型的选择会影响生产复杂性、保质期管理和产品宣称，咀嚼片产品通常因其便利性和「零食般」的特性而享有高端定位。

全面的区域洞察：说明美洲、欧洲、中东和非洲以及亚太地区如何制定产品、分销管道和监管策略，以支持全球扩张。

了解区域差异对国际成长至关重要，因为区域趋势会显着影响产品策略、通路选择和监管规划。在美洲，消费者需求偏向优质化和实证产品，线上和量贩店通路渗透率很高。该地区通常强调便利性、口味多样性和临床可信度，并且往往是订阅和会员忠诚度计划的试验场。跨境贸易流动和区域法规结构进一步影响产品配方选择和标籤标註规范。

关键竞争情报重点分析配方科学、兽医领导企业以及分销管道执行如何使犬类关节保健品市场的领导者与追随者区分开来

犬用葡萄糖胺市场的竞争动态主要围绕着配方差异化、分销管道覆盖以及兽医专业人士的信任度。主要企业采取不同的策略，一些企业强调以临床试验和兽医推荐为支撑的高端复合配方，而另一些企业则以高性价比、大批量、低成本的产品形式，针对大众分销渠道进行竞争。品牌历史和信任度也影响竞争定位，新参与企业则利用数位行销和订阅模式来推动产品试用。

为行业领导者提供切实可行的优先建议，帮助他们透过配方策略、数位化分销、供应商韧性和增强监管信心来建立商业性优势。

针对行业领导者的具体建议着重于使产品蓝图、商业模式和营运能力与当前市场实际情况相符。首先，应优先考虑兼顾证据、偏好和生产可行性的配方策略。整合互补活性成分的组合配方，若有清晰的作用机制证据和稳定性数据支持，则可确立高端市场定位。其次，应加速数位化优先分销，同时与宠物专卖零售商和兽医通路保持策略合作关係。应利用厂商直销管道收集第一方数据，并检验订阅和个人化方案；同时，应利用第三方市场平台扩大品牌知名度并降低获客成本。

对支撑本分析的混合方法研究（结合一手访谈、产品审核、第二手资料分析和资料检验）进行清晰的解释，以支援实际应用。

本分析的调查方法结合了定性和定量技术，以确保得出严谨且可操作的结果。主要研究包括对供应链相关人员、配方科学家、采购主管、零售商和兽医专业人士进行深度访谈，以获取有关功效预期、通路经济效益和供应商能力的第一手资讯。此外，还对产品和包装进行了审核，评估了代表性SKU的配方声明、口味组合和生产特性。

简要概述强调了整合产品可靠性、弹性营运和全通路策略执行以实现持续价值的必要性。

总之，犬用葡萄糖胺补充剂市场正处于一个转折点，产品科学、不断发展的分销管道和贸易动态正在融合，共同塑造竞争优势。宠物饲主对产品功效、安全性和便利性的期望日益提高，能够透过复杂的配方、临床检验和透明的采购流程清晰展现差异化价值的公司将赢得消费者的忠诚。同时，将厂商直销与精选零售商和兽医伙伴关係结合的分销策略，将优化客户获取和维繫的经济效益。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 犬用葡萄糖胺补充剂市场按剂型划分

  • 咀嚼型
    • 牛肉风味
    • 鸡
    • 花生酱
  • 液体类型
  • 粉末
  • 药片

9. 犬用葡萄糖胺补充剂市场按成分类型划分

  • 盐酸盐
  • N-乙酰
  • 硫酸盐

第十章 犬用葡萄糖胺补充剂市场（按成分划分）

  • 混合型
    • 软骨素
    • 玻尿酸
    • MSM
  • 单件

第十一章 犬用葡萄糖胺补充剂市场（按分销管道划分）

  • 量贩店
  • 在线的
    • 製造商官方网站
    • 第三方市场
  • 宠物专卖店
  • 兽医诊所

第十二章 犬用葡萄糖胺补充剂市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 犬用葡萄糖胺补充品市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国犬用葡萄糖胺补充剂市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国犬用葡萄糖胺补充剂市场

第十六章：中国犬用葡萄糖胺补充剂市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Ainsworth Pet Nutrition LLC
  • All Living Things, Inc.
  • Biovencer Healthcare Private Limited
  • Elanco Animal Health Incorporated
  • Nestle Purina PetCare Company
  • Nutramax Laboratories, Inc.
  • PetLab Co., Inc.
  • TSI Group Ltd.
  • VetIQ, LLC
  • VetriScience Laboratories, Inc.
  • VetsPlus USA, Inc.
  • Zesty Paws IP, LLC
Product Code: MRR-9A6A6F2977E7

The Glucosamine Supplement for Dog Market was valued at USD 236.44 million in 2025 and is projected to grow to USD 257.55 million in 2026, with a CAGR of 7.27%, reaching USD 386.54 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 236.44 million
Estimated Year [2026] USD 257.55 million
Forecast Year [2032] USD 386.54 million
CAGR (%) 7.27%

Introductory framing that clarifies the strategic intersection of product innovation, supply chain resilience, and evolving pet owner expectations in the canine joint health arena

This introduction establishes the strategic context for stakeholders operating in the canine glucosamine supplement space and explains why a focused, evidence-driven approach is essential today. The category sits at the intersection of evolving pet owner expectations, advances in formulation science, and a distribution landscape that increasingly privileges convenience and clinical credibility. Consequently, companies must reconcile product innovation with supply chain resilience, regulatory compliance, and differentiated go-to-market models to remain competitive.

Pet owners are treating companion animals as family members, which has altered purchasing behaviours and elevated demand for premium, science-backed supplements. At the same time, ingredient innovation-such as variations in glucosamine forms and complementary agents-has expanded the formulation toolkit, enabling targeted positioning for life-stage, palatability, and combined therapeutic benefits. Against this backdrop, manufacturers and distributors are pressed to demonstrate both efficacy and safety through transparent labeling, third-party testing, and partnerships with veterinary professionals.

Moreover, the operational environment is becoming more complex as trade policies, logistics constraints, and channel economics shift. In response, successful players are prioritizing agility in procurement, digital-first consumer engagement, and data-driven segmentation to deliver tailored offerings. This introduction therefore sets up an imperative: firms must integrate product science, channel strategy, and supply chain tactics to seize growth opportunities while managing emerging risks.

Compelling analysis of the pivotal shifts driving product differentiation, omnichannel distribution, and supply chain transparency in the canine supplement market

The landscape for canine glucosamine supplements is undergoing transformative shifts that are reshaping competitive dynamics and value creation across the product lifecycle. First, consumer expectations have matured beyond simple symptom relief toward holistic joint health solutions, which is driving demand for combination compositions, adjunctive actives, and evidence-oriented claims. This evolution forces brands to invest in clinical validation and to articulate differentiated value propositions that resonate with veterinarians and discerning pet owners alike.

Second, distribution has shifted meaningfully toward omnichannel models where digital touchpoints substantially influence discovery and repeat purchase. While traditional mass merchants and pet specialty stores retain importance, online channels-both brand-owned and third-party marketplaces-are now central to customer acquisition and subscription models. Consequently, firms that integrate digital analytics with commerce functions gain faster insight into lifetime value and product performance across cohorts.

Third, ingredient sourcing and formulation choices are being re-assessed in light of logistical pressures and regulatory scrutiny. Manufacturers are experimenting with alternative glucosamine salts and complementary ingredients to optimize bioavailability, palatability, and manufacturing robustness. Finally, stakeholder expectations around sustainability, traceability, and responsible marketing are rising, requiring transparent supply chains, clean-label claims, and credible third-party certifications. Together, these shifts mandate cross-functional strategies that align R&D, manufacturing, regulatory affairs, and commercial teams to deliver differentiated, trusted products at scale.

Rigorous assessment of how tariff-driven trade shifts in 2025 forced supply chain reconfiguration, pricing realignment, and strategic supplier diversification across the value chain

The cumulative impact of U.S. tariffs and related trade dynamics in 2025 has reverberated through the canine supplement value chain, prompting strategic reassessment of sourcing, pricing, and inventory practices. Increased import duties and heightened customs scrutiny have elevated landed costs for certain ingredient categories and packaging components, which in turn has pressured gross margins and necessitated adjustments to commercial strategies. In response, many organizations undertook portfolio rationalization to prioritize higher-margin SKUs and to defer lower-performing SKUs while they evaluated sourcing alternatives.

As a result of these trade shifts, procurement teams accelerated supplier diversification efforts and explored nearshoring to mitigate exposure to tariff volatility and transit disruptions. This reorientation often required new supplier qualification protocols, heightened quality assurance oversight, and capital allocation to support dual-sourcing contracts and safety stock. Simultaneously, logistics teams re-engineered inbound flows to optimize for consolidated shipments, bonded warehousing, and improved customs classification to minimize duty liabilities.

Market-facing teams translated these operational adjustments into revised channel tactics. Retail pricing strategies were rebalanced to reflect increased cost bases while protecting core consumer segments through targeted promotions and subscription incentives. At the same time, the tariff environment strengthened the case for vertical integration for some manufacturers that could internalize critical processing steps to control input costs and quality. Cumulatively, the tariff-driven changes have accelerated structural shifts toward resilient supply chains, differentiated channel mixes, and sharper portfolio management.

In-depth segmentation synthesis revealing how form, ingredient chemistry, channel dynamics, life-stage targeting, and combination compositions determine commercial opportunity and operational priorities

Segment-level insights reveal where product, channel, and life-stage strategies intersect and where differentiation can create sustainable advantage. Based on Form, the market is studied across chewable, liquid, powder, and tablet formats; chewable formats further segment by popular flavors such as beef, chicken, and peanut butter, which influence palatability and repeat purchase among companion animals. Form choice impacts manufacturing complexity, shelf-life management, and claims architecture, with chewables often commanding premium positioning due to convenience and perceived treat-like attributes.

Based on Ingredient Type, the market is studied across hydrochloride, N acetyl, and sulfate variants; each form presents trade-offs in perceived efficacy, sourcing availability, and cost-to-formulate. Product teams must therefore match ingredient selection with clinical evidence, stability profiles, and regulatory considerations to craft clear comparative messaging. Based on Distribution Channel, the market is studied across mass merchant, online, pet specialty store, and veterinary pathways; within online distribution, nuance matters as manufacturer website commerce and third-party marketplace placements deliver different economics, data visibility, and brand control. This channel segmentation informs assortment decisions, promotional cadence, and service levels for subscription fulfillment.

Based on Dog Age, the market is studied across adult, puppy, and senior cohorts, reflecting differing needs for palatability, dosing frequency, and supportive adjuncts; senior dogs typically drive demand for joint support, but puppy formulations present opportunities for preventive positioning. Based on Composition, the market is studied across combination and single formulations; combination offerings are further analyzed across inclusion of chondroitin, hyaluronic acid, and MSM, which enable multi-mechanistic approaches to joint health and create avenues for differentiated claims and premium pricing. Integrating these segmentation lenses allows stakeholders to design targeted R&D, manufacturing, and marketing plans that align with consumer preferences and channel economics.

Comprehensive regional insights describing how the Americas, Europe Middle East & Africa, and Asia-Pacific each shape product, channel, and regulatory strategies for global expansion

Regional dynamics materially influence product strategy, channel choice, and regulatory planning, and a nuanced view of geographies is essential for international growth. In the Americas, consumer demand skews toward premiumization and evidence-based products, with strong penetration of online and mass merchant channels; this region typically emphasizes convenience, flavor variety, and clinical credentials, and it is often a proving ground for subscription and loyalty mechanics. Cross-border trade flows and regional regulatory frameworks further shape formulation choices and labeling practices.

In Europe, Middle East & Africa, regulatory diversity and heterogeneous retail structures require flexible market entry strategies, localized labeling, and sometimes reformulation to meet national standards. In this macro-region, specialty pet retailers and veterinary channels can be influential for premium and clinically oriented products, while e-commerce growth varies significantly across individual markets, demanding tailored digital strategies. Asia-Pacific presents a mosaic of opportunity driven by rapid pet ownership growth, rising discretionary spend on companion animals, and distinct preferences for formats and flavors; distribution here often involves hybrid models that combine traditional pet specialty channels with rapidly expanding online marketplaces. Understanding the regulatory regimes, consumer trust drivers, and distribution idiosyncrasies across these regions is vital for scaling product lines, negotiating trade terms, and sequencing market launches.

Key competitive intelligence focused on how formulation science, veterinary partnerships, and channel execution separate leaders from followers in canine joint supplement markets

Competitive dynamics in the canine glucosamine category center on the interplay between formulation differentiation, channel presence, and credibility with veterinary professionals. Leading firms pursue distinct paths: some emphasize premium, combination formulations supported by clinical trials and veterinarian endorsements, while others compete on value through higher-volume, lower-cost formats optimized for mass channels. Competitive positioning is also influenced by brand heritage and trust, with newer entrants leveraging digital-native marketing and subscription models to accelerate trial.

Partnerships with veterinary clinics and opinion leaders remain a decisive factor for market acceptance of novel formulations and claims, as veterinarians often act as trusted gatekeepers for pet health interventions. In parallel, retail-channel strategies-spanning mass merchant listings, pet specialty assortments, and curated manufacturer storefronts online-determine discoverability and repeat purchase economics. Manufacturing capacity, access to high-quality API suppliers, and the ability to maintain consistent product quality under heightened regulatory scrutiny differentiate firms operationally. Ultimately, companies that align scientific validation with robust channel execution and transparent ingredient sourcing are better positioned to convert consumer intent into sustained loyalty.

Practical and prioritized recommendations directing leaders to fortify formulation strategies, digital distribution, supplier resilience, and regulatory credibility for commercial advantage

Actionable recommendations for industry leaders focus on aligning product roadmaps, commercial models, and operational capabilities to current market realities. First, prioritize formulation strategies that balance evidence, palatability, and manufacturing feasibility; combination formulations that integrate complementary actives can command premium positioning when supported by clear mechanistic rationale and stability data. Second, accelerate digital-first distribution while preserving strategic relationships with pet specialty and veterinary channels; manufacturer-owned commerce should be used to capture first-party data and to test subscription and personalization initiatives, while third-party marketplaces can scale awareness and lower acquisition costs.

Third, strengthen sourcing resilience through supplier diversification and modular supply agreements that allow rapid shifts between ingredient forms such as hydrochloride, N acetyl, and sulfate variants without compromising product integrity. Fourth, invest in regulatory intelligence and label transparency to preempt compliance challenges across geographies and to earn trust with veterinarians and informed consumers. Finally, deploy segmented marketing tactics keyed to life-stage cohorts-adult, puppy, and senior-and to form preferences like chewable flavors and delivery format to improve conversion and lifetime value. Implementing these recommendations requires cross-functional roadmaps with clear owners, timelines, and success metrics to translate strategic intent into market impact.

Transparent explanation of the mixed-methods research approach combining primary interviews, product audits, secondary synthesis, and data triangulation to support actionable insights

The research methodology underpinning this analysis combines qualitative and quantitative techniques to ensure rigorous, actionable outputs. Primary research included in-depth interviews with supply-side stakeholders, formulation scientists, procurement leads, retail merchandisers, and veterinary professionals to capture firsthand perspectives on efficacy expectations, channel economics, and supplier capabilities. These interviews were complemented by product and packaging audits that assessed formulation claims, flavor assortments, and manufacturing attributes across representative SKUs.

Secondary research synthesized regulatory guidance documents, industry publications, and trade data to map tariff impacts, logistics trends, and trade compliance considerations. Data triangulation was applied to reconcile divergent inputs and to surface robust insights without relying on single-source assertions. Analytical techniques included segmentation cross-tabulation, channel profitability assessment, and scenario analysis to evaluate strategic options under different supply chain and trade conditions. To bolster transparency, methodological limitations and assumptions were documented, and key informant quotations were retained where appropriate to illustrate stakeholder sentiment. This mixed-methods approach enables confidence in the directional findings and the recommended strategic pathways.

Concise concluding synthesis emphasizing the necessity of integrating formulation credibility, resilient operations, and omnichannel execution to capture enduring value

In conclusion, the canine glucosamine supplement category is at an inflection point where product science, channel evolution, and trade dynamics jointly shape competitive advantage. Pet owners' expectations for efficacy, safety, and convenience are rising, and companies that can credibly demonstrate differentiated value-through combination formulations, clinical validation, and transparent sourcing-will capture disproportionate loyalty. Meanwhile, distribution strategies that integrate manufacturer-owned commerce with selective retail and veterinary partnerships will optimize acquisition and retention economics.

Operational resilience remains essential in a context marked by tariff-related cost pressure and supply chain complexity. Firms that proactively diversify suppliers, optimize inventory strategies, and strengthen customs and compliance capabilities will be better positioned to sustain margins and service levels. Ultimately, translating these insights into concrete outcomes requires disciplined prioritization, cross-functional execution, and continuous feedback loops between R&D, supply chain, and commercial teams. By aligning science-led product development with resilient operations and thoughtful channel strategy, organizations can convert market shifts into lasting advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Glucosamine Supplement for Dog Market, by Form

  • 8.1. Chewable
    • 8.1.1. Beef
    • 8.1.2. Chicken
    • 8.1.3. Peanut Butter
  • 8.2. Liquid
  • 8.3. Powder
  • 8.4. Tablet

9. Glucosamine Supplement for Dog Market, by Ingredient Type

  • 9.1. Hydrochloride
  • 9.2. N Acetyl
  • 9.3. Sulfate

10. Glucosamine Supplement for Dog Market, by Composition

  • 10.1. Combination
    • 10.1.1. Chondroitin
    • 10.1.2. Hyaluronic Acid
    • 10.1.3. Msm
  • 10.2. Single

11. Glucosamine Supplement for Dog Market, by Distribution Channel

  • 11.1. Mass Merchant
  • 11.2. Online
    • 11.2.1. Manufacturer Website
    • 11.2.2. Third Party Marketplace
  • 11.3. Pet Specialty Store
  • 11.4. Veterinary

12. Glucosamine Supplement for Dog Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Glucosamine Supplement for Dog Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Glucosamine Supplement for Dog Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Glucosamine Supplement for Dog Market

16. China Glucosamine Supplement for Dog Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Ainsworth Pet Nutrition LLC
  • 17.6. All Living Things, Inc.
  • 17.7. Biovencer Healthcare Private Limited
  • 17.8. Elanco Animal Health Incorporated
  • 17.9. Nestle Purina PetCare Company
  • 17.10. Nutramax Laboratories, Inc.
  • 17.11. PetLab Co., Inc.
  • 17.12. TSI Group Ltd.
  • 17.13. VetIQ, LLC
  • 17.14. VetriScience Laboratories, Inc.
  • 17.15. VetsPlus USA, Inc.
  • 17.16. Zesty Paws IP, LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY BEEF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY BEEF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY BEEF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHICKEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHICKEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHICKEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY PEANUT BUTTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY PEANUT BUTTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY PEANUT BUTTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY HYDROCHLORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY HYDROCHLORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY HYDROCHLORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY N ACETYL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY N ACETYL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY N ACETYL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY SULFATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY SULFATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY SULFATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHONDROITIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHONDROITIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHONDROITIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY HYALURONIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY HYALURONIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY MSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY MSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY MSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY SINGLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY SINGLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY SINGLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY MASS MERCHANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY MASS MERCHANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY MASS MERCHANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY THIRD PARTY MARKETPLACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY THIRD PARTY MARKETPLACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY THIRD PARTY MARKETPLACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY PET SPECIALTY STORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY PET SPECIALTY STORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY PET SPECIALTY STORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY VETERINARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY VETERINARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY VETERINARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 146. GCC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 148. GCC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 149. GCC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. GCC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 151. GCC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 152. GCC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. GCC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 170. G7 GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 172. G7 GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 173. G7 GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. G7 GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 175. G7 GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 176. G7 GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. G7 GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 178. NATO GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. NATO GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 180. NATO GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 181. NATO GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. NATO GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 183. NATO GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 184. NATO GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. NATO GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)